"We are excited to welcome Dr. Mannick as our Head of R&D," said Life Biosciences Chief Executive Officer Mehmood Khan. "Joan's expertise aligns so closely with our vision of pursuing therapies for age-related diseases by targeting the biological causes of aging, and I'm confident she will help us take Life Biosciences to the next level."
Dr. Mannick has more than 20 years of industry experience, most recently as Co-Founder and Chief Medical Officer at Adicet Bio, formerly resTORbio. She has also held senior positions with Novartis Institutes of Biomedical Research and Genzyme Corporation, and has been a faculty member at Harvard Medical School and University of Massachusetts Medical School.
"I am thrilled to join Life Biosciences because I think it has in-licensed the most exciting programs of any company in the aging field," said Dr. Mannick. "With truly inspiring science and an incredibly talented team of world-leading researchers, Life Biosciences has huge potential to change the course of aging and age-related diseases, and I am honored to now be a part of it."